Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Compass Therapeutics, Inc. CMPX |
FMR LLC | 6,872,414 7.010% |
2,750,000 (+66.71%) |
Filing History |
| 2021-12-30 4:40 pm Purchase |
2021-12-20 | 13G | Compass Therapeutics, Inc. CMPX |
Rock Springs Capital Management LP | 5,324,017 5.430% |
5,324,017 (New Position) |
Filing History |
| 2021-12-17 3:14 pm Purchase |
2021-12-17 | 13G | Compass Therapeutics, Inc. CMPX |
ANDERSON ERRIK | 3,546,730 3.600% |
3,546,730 (New Position) |
Filing History |
| 2021-11-12 06:10 am Purchase |
2021-11-02 | 13G | Compass Therapeutics, Inc. CMPX |
Foresite Capital Fund V L.P. | 5,500,000 5.600% |
5,500,000 (New Position) |
Filing History |
| 2021-11-09 5:30 pm Purchase |
2021-11-04 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 18,071,547 18.400% |
5,357,143 (+42.13%) |
Filing History |
| 2021-07-14 5:08 pm Purchase |
2021-07-09 | 13D | Compass Therapeutics, Inc. CMPX |
ORBIMED ADVISORS LLC | 12,714,404 20.400% |
12,714,404 (New Position) |
Filing History |
| 2021-02-08 10:19 am Purchase |
2021-02-05 | 13G | Compass Therapeutics, Inc. CMPX |
FMR LLC | 4,122,414 6.744% |
4,122,414 (New Position) |
Filing History |
| 2020-08-10 09:23 am Purchase |
2020-06-19 | 13G | Compass Therapeutics, Inc. CMPX |
FMR LLC | 2,781,497 5.333% |
21,417 (+0.78%) |
Filing |